drugset / Trial / NCT02115776

A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures

NCT02115776

RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to evaluate the efficacy of prophylactic dosage with amoxicillin (AMX), amoxicillin-clavulanate (AMX-CLV), and a combination of amoxicillin-clavulanate and a chlorhexidine mouthwash (AMX-CLV-CHX) in the prevention of bacteremia following dental extractions. The study hypothesis is that an antimicrobial regimen with amoxicillin-clavulanate will show higher effectiveness in reducing the prevalence and duration of bacteremia following dental extractions, than that achieved with the classical amoxicillin regimen.

Timeline

Start
2014-01
Primary completion
2015-04
Completion
2015-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 2 g Intravenous
Subject Amoxicillin-Potassium Clavulanate Unknown 200 mg Intravenous
Subject Amoxicillin-Potassium Clavulanate Unknown 1000 mg Intravenous
Subject Chlorhexidine Small molecule 0.2 % Other